Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Key value for chemical safety assessment

Additional information


These two core substances are so closely related structurally that they are best examined together.

There are no experimental studies on the toxicokinetics of propoxylated ethane-1,2-diol or propoxylated 2,2’-oxydiethanol. The toxicokinetics of the core substances and the repeating unit are summarised in Illing and Barratt (2007 revised 2009). Both core substances have two free hydroxy groups, thus NLP polyols are likely to consist predominantly of chains of between one and two repeating units, with some chains containing three repeating units.

For the calculations of bioavailability of the commercial NLP polyol, logP values were calculated using the incremental fragment method of Suzuki and Kudo (1990). The propoxy groups have an important effect on the toxicity by modulating any toxicity arising from the core substance. The substitution of a hydroxyl group on a core compound by a propoxy group increases its logP value by 0.24 units and its molecular weight by 58Daltons. The combined effect of these changes is to reduce the bioavailability by a factor of 1.53 (calculated using the Potts and Guy equation). MEG + 3PO indicates the component representing the mean toxicity.

Given the vapour pressure and water solubility of the commercial preparation, it is likely that absorption of some of the lower molecular weight components may occur via the lung.

Ethane1,2-diol, oxydiethanol, 2,2’-(ethylenedioxy)diethanol, propane-1,2-diol, oxydipropanol  and [(methylethylene)bis(oxy)]dipropanol are absorbed, probably by passive diffusion, when administered orally. Thus it is probable that low number oligomers will be absorbed. The calculated logP suggests that the component representing the mean toxicity of the commercial preparation is likely to be absorbed orally.

Given the logP values, it is likely that any absorbed oligomers of  propoxylated etahne-1,2-diol or 2,2’-oxydiethanol will be widely distributed in the body.  As metabolism is likely, it is unlikely that they will accumulate in tissues.

In the event that higher molecular weight material is absorbed, it is likely to be excreted in bile. Lower molecular weight unmetabolised oligomer is likely to be excreted in urine. In rat the molecular weight threshold for biliary excretion is around 350, in human it is about 500 (Illing, 1989). The material most likely to be absorbed is likely to be hydrolysed and the products appear in urine. Some carbon dioxide might be formed from hydrolysis of the propane-1,2-diol groups and exhaled.

Based on information from ethane-1,2-diol, oxydiethanol, and (ethylenedioxy)diethanol, propane-1,2-diol, oxydipropanol  and [(methylethylene)bis(oxy)]dipropanol it is likely some material may be hydrolysed, some oxidation of one or both of the terminal alcohol groups to the corresponding mono and di-carboxylic acids may occure or, possibly some conjugation of the terminal alcohol groups with glucuronic acid and/or sulphate may also be possible. At low doses some further metabolism to carbon dioxide may occur.